“…Dreyfus, Schapira, and Demos (1960) have recently pointed out the advantage of determining serum levels of this enzyme in the investigation of muscle disease. Colombo et al (1962), Hughes (1963), and others (Ebashi, Toyokura, Momoi, and Sugita, 1959), have found high levels of creatine phosphokinase in the serum of patients with progressive muscular dystrophy. These levels may also be useful in the diagnosis of acute myocardial infarction, especially in differentiating between myocardial and pulmonary infarction (Dreyfus, Schapira, Resnais, and Scebet, 1960;Stich and Tsirimbas, 1962).…”